Lebanese Professor Wins Great Arab Minds Award in Technology, Engineering

Lebanese professor Fadil Adib. Asharaq Al-Awsat
Lebanese professor Fadil Adib. Asharaq Al-Awsat
TT

Lebanese Professor Wins Great Arab Minds Award in Technology, Engineering

Lebanese professor Fadil Adib. Asharaq Al-Awsat
Lebanese professor Fadil Adib. Asharaq Al-Awsat

Lebanon’s Fadil Adib, associate professor at the Massachusetts Institute of Technology (MIT), won the Great Arab Minds Award 2023 in engineering and technology, for his contributions that have significantly expanded the possibilities of wireless sensing technology, enabling detection behind walls and the use of wireless waves in medicine and search for survivors under the rubble.

Sheikh Mohammed bin Rashid, vice president and ruler of Dubai, said innovation and creative engineering have always contributed to the progress of humanity, and were a major part of the Arab civilization, which the younger generations are looking forward to resume and to contribute to its achievements using technology and digitization.

"Today, we proudly announce the winner of the Great Arab Minds Award in engineering and technology, Professor Fadil Adib from Lebanon. He has published over 80 research papers and holds patents in the fields of engineering and technology. His significant contributions have served humanity in vital fields such as healthcare, wireless sensing and oceans exploration,” he added.

"Today, in the Arab world, we have millions of programmers, engineers, computer scientists, and technology experts who are capable of producing an effective knowledge and development movement in their societies, economies and world. The Great Arab Minds initiative aims to honor the achievements of creative people among them so they can serve as role models for their peers,” the Ruler of Dubai said.

"With their achievements and in their various positions, Arabs are the ambassadors of values, capabilities and aspirations of the young Arab generations eager to develop their societies and advance humanity,” he noted.

Adib developed a battery-free device that harness energy from ocean waves.

His doctoral dissertation, “See through Wall”, was named as one of the best 50 transformative contributions from MIT in computer science in the past 50 years.

Launched by Sheikh Mohammed bin Rashid, the Great Arab Minds Award is aimed at introducing and celebrating the brightest minds in the Arab world, as well as honoring those whose works left remarkable impact in their societies. The award also reflects the ruler’s support of innovation and scientific, cultural and intellectual advancement in the region.

Fadel’s leading research and inventions have contributed to expanding the possibilities of wireless sensing technology and progressing in fields that are vital for the future of development in the Arab region and the world.

He harnessed wi-fi techniques in sensing what’s behind walls, enabling the detection of objects and vibrations. This advanced technology can be used to monitor patients' health conditions around the clock, and in search and rescue operations under rubble and during disasters.

For his part, Mohammad bin Abdullah Al Gergawi, chairman of the Great Arab Minds initiative, said: "The Arab world has promising talents in advanced technology and creative engineering that are capable of providing unprecedented added value to human knowledge and progress.”

He called on Arab youth to be inspired by the experiences of Arab geniuses such as Adib.

The announcement of the winner in the engineering and technology category comes after completing all stages of receiving, sorting, and evaluating nominations within the six categories: engineering and technology, medicine, economics, architecture and design, natural sciences, and literature and arts.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”